Haemophilia trials in Mexico

5 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Where

  Mérida

  Age

  1 year to 74 years

  People

  245 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05145127 · EU 2022-500470-33-00
• No phaseTaking people
  An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A

  Where

  Many Locations

  Age

  7 years to 12 years

  People

  40 worldwide

  Run by

  Bayer

  See details and how to joinNCT07088458
• Phase 3Taking people
  A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

  Where

  Veracruz

  Age

  1 year to 17 years

  People

  100 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05611801 · EU 2022-500495-65-00
• Phase 3Taking people
  Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

  Where

  Mexico City

  Age

  18 years and over

  People

  35 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT06003387 · EU 2023-509590-23-00
• No phaseTaking people
  Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

  Where

  Jalisco, Morelia, Nuevo León

  People

  200 worldwide

  Run by

  Octapharma

  See details and how to joinNCT03695978